http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2005521660-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D317-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D317-34
filingDate 2003-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2005-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2005521660-A
titleOfInvention Process for producing dioxolane nucleoside analogues
abstract The present invention relates to a process for preparing a dioxolane nucleoside analog of formula I or a pharmaceutically acceptable salt thereof, carried out in one reaction vessel, the process comprising a Lewis acid, a silylating agent. And adding a dioxolane of formula II to a non-silylated purine base or pyrimidine base or analog thereof. The present invention also provides a process for preparing a dioxolane compound of formula III by reacting a dioxolane compound of formula IV in a suitable solvent in the presence of DIB and I 2 using a suitable energy source. provide.
priorityDate 2002-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12009
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466596295
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414991790
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465989001
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415906860
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419482568
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22949012
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID140261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164134162
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164163500
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466061139
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID79143
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425363617
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164106254
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135403591
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14351762
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11564692
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467957603
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410930822
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467957583
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415843444
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466032399
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411671236
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468183455
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465947877
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468181724
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419541966
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468307955
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID255391

Total number of triples: 49.